Dr. Smith's ECG Blog

NOVEMBER 3, 2023

Written by Nathanael Franks MD, reviewed by Meyers, Smith, Grauer, etc. A man in his 70s with past medical history of hypertension, dyslipidemia, CAD s/p left circumflex stent 2 years prior presented to the ED with worsening intermittent exertional chest pain relieved by rest. This episode of chest pain began 3 hours ago and was persistent even at rest.

Chest Pain 86

Chest Pain Cardiogenic Shock Ischemia Myocardial Infarction 86

Society of Thoracic Surgeons - Surgeon

NOVEMBER 3, 2023

Webinar Sublobar Resection Versus Lobectomy for Early-Stage Lung Cancer: A Debate dkaczmarek Fri, 11/03/2023 - 10:43 November 16, 2023 Part 1 of a 2-part webinar series, supported by AstraZeneca During this webinar, the expert panel will discuss two recently published clinical trials (CALGB 140503 and JCOG 0802) that demonstrate equivalent survival for sublobar resection versus lobectomy for clinical stage IA cancer, peripheral <2cm.

Cancer 52

Cancer Webinar Biomarkers Hospital 52

Physiologically Speaking

NOVEMBER 3, 2023

Greetings! Welcome to the Physiology Friday newsletter. This newsletter is brought to you by Examine.com and my new eBook, “VO2 Max Essentials”, details for which can be found at the end of this newsletter. Physiologically Speaking is a reader-supported publication. To receive new posts and support my work, consider becoming a free or paid subscriber.

Physiology 52

Physiology 52

Journal of Cardiovascular Electrophysiology

NOVEMBER 3, 2023

Graphical abstract depicting cardiac arrest mortality disparities in the young, temporal trends, and its correlation with the social vulnerability index. Abstract Background Cardiac arrest (CA) is a leading cause of death in the United States (US). Social determinants of health may impact CA outcomes. We aimed to assess mortality trends, disparities, and the influence of the social vulnerability index (SVI) on CA outcomes in the young.

Cardiac Arrest 40

Cardiac Arrest Certification Outcomes Article 40

European Journal of Heart Failure

NOVEMBER 3, 2023

Among 475 patients with cardiac sarcoidosis, 119 (25.1%) were isolated cardiac sarcoidosis (iCS) based on the 2016 Japanese Circulation Society criteria. Patients with iCS were more likely to have a history of atrial fibrillation (AF) or hospitalization for heart failure (HF), or lower left ventricular ejection fraction (LVEF) than those with systemic cardiac sarcoidosis.

Atrial Fibrillation 40

Atrial Fibrillation Heart Failure Tachycardia Arrhythmia 40

Circulation: Cardiovascular Quality & Outcomes

NOVEMBER 3, 2023

Circulation: Cardiovascular Quality and Outcomes, Volume 16, Issue 11 , Page e010086, November 1, 2023. BACKGROUND:In January 2014, the American College of Cardiology/American Heart Association released a policy statement arguing for the inclusion of cost-effectiveness analysis (CEA) and value assessments in clinical practice guidelines. It is unclear whether subsequent guidelines changed how they incorporated such concepts.METHODS:We analyzed guidelines of cardiovascular disease subconditions w

Article 40

Article Cardiovascular Disease Circulation Outcomes 40

Circulation: Arrhythmia and Electrophysiology

NOVEMBER 3, 2023

Circulation: Arrhythmia and Electrophysiology, Volume 16, Issue 11 , Page e012043, November 1, 2023. BACKGROUND:In patients with persistent atrial fibrillation (PersAF), catheter ablation aiming for pulmonary vein isolation (PVI) is associated with moderate clinical effectiveness. We investigated the benefit of continuing previously ineffective class 1C or 3 antiarrhythmic drug therapy (ADT) in the setting of a standardized PVI-only ablation strategy.METHODS:In this multicenter, randomized contr

Atrial Fibrillation 40

Atrial Fibrillation Pulmonary Quality of Life Ablation 40

Circulation: Arrhythmia and Electrophysiology

NOVEMBER 3, 2023

Circulation: Arrhythmia and Electrophysiology, Volume 16, Issue 11 , Page e012543, November 1, 2023.

Cardiomyopathy 40

Cardiomyopathy Electrophysiology Arrhythmia Circulation 40

Journal of Cardiovascular Pharmacology

NOVEMBER 3, 2023

Abstract: The current work was aimed at exploring the association between single nucleotide polymorphisms(SNPs) in the ICAM-1 gene, along with the identification of additional haplotypes and their potential role in susceptibility to ischemic cardiomyopathy(ICM). The control group underwent a Hardy-Weinberg equilibrium test. The associations of genotypes and alleles with susceptibility to ICM were then analyzed using logistic regression analysis.

Cardiomyopathy 40

Cardiomyopathy Article 40

Circulation: Arrhythmia and Electrophysiology

NOVEMBER 3, 2023

Circulation: Arrhythmia and Electrophysiology, Volume 16, Issue 11 , Page e012300, November 1, 2023.

Electrophysiology 40

Electrophysiology Arrhythmia Ablation Circulation 40

Journal of Cardiovascular Pharmacology

NOVEMBER 3, 2023

Abstract: Cardiovascular disease continues to be the leading cause of mortality globally. Modifiable risk factors, such as hypertension and dyslipidemia can be managed through lifestyle and pharmacotherapy treatments to reduce the risk of primary and secondary major cardiovascular events in patients with elevated risk. Despite effective and available medications to manage and mitigate cardiovascular risk factors, control rates of hypertension and dyslipidemia are suboptimal and greater efforts a

Risk Factors 40

Risk Factors Cardiovascular Disease Hypertension Article 40